Visual Screening for Malignant Melanoma
Open Access
- 1 January 2007
- journal article
- research article
- Published by American Medical Association (AMA) in Archives of Dermatology
- Vol. 143 (1) , 21-28
- https://doi.org/10.1001/archderm.143.1.21
Abstract
Melanoma is the only cancer for which incidence and mortality rates are rising unabated, while screening, the potential means for reducing the burden of disease, continues to be underused.1 In contrast to other early detectable cancers, including breast, prostate, colorectal, and cervical cancers, with recently decreasing mortality rates, the mortality rate for melanoma in the United States increased by 29% from 1975 to 2000.1,2Keywords
This publication has 35 references indexed in Scilit:
- Cost-Effectiveness of Human Papillomavirus DNA Testing for Cervical Cancer Screening in Women Aged 30 Years or MoreObstetrics & Gynecology, 2004
- Screening for melanomaDermatologic Clinics, 2002
- Strategies for improving melanoma education and screening for men age ≥ 50 yearsCancer, 2002
- Screening for skin cancer22: Recommendations and rationaleAmerican Journal of Preventive Medicine, 2001
- Risk of cutaneous melanoma associated with a family history of the diseaseInternational Journal of Cancer, 1995
- Melanoma Recurrence Surveillance Patient or Physician Based?Annals of Surgery, 1995
- Cost - Effectiveness Analysis, Extended Dominance, and EthicsMedical Decision Making, 1994
- Markov Models in Medical Decision MakingMedical Decision Making, 1993
- The Beaver Dam Health Outcomes studyMedical Decision Making, 1993
- Thickness, Cross-Sectional Areas and Depth of Invasion in the Prognosis of Cutaneous MelanomaAnnals of Surgery, 1970